Ampli®cation and over-expression of the N-myc oncogene is associated with the progression of neuroblastoma in children and in a nude mouse model system. Neuroblastoma cell lines with widely dierent levels of N-myc illustrate an inverse relationship between N-myc over-expression and reduced expression of several integrin extracellular matrix receptors. Transfection and over-expression of N-myc in a neuroblastoma cell line not normally expressing the protein resulted in cells that grew loosely associated with tissue culture plates; this correlated with reduced levels of b1 integrin subunit. Evidence is now presented that a2 and a3 integrin subunit levels are also reduced in cells that over-express N-myc, with virtually no association of a2 or a3 subunits with b1. Consequently, maturation of the b1 subunit and cell surface expression of the integrins are greatly reduced in N-myc-transfected cells. A small amount of b1 protein does get to the cell surface, however, suggesting that an as yet unidenti®ed a subunit is produced by the N-myc-expressing cells. Finally, the observed reductions in integrin protein levels are re¯ections of greatly reduced levels of integrin a2 and a3 mRNAs, as well as a smaller reduction in b1 mRNA (80%, 94% and 52%, respectively). Post-transcriptional mechanisms modulating b1 integrin levels are also operative. These results indicate that over-expression of N-myc from a transfected gene in a neuroblastoma cell line that does not normally produce the protein generates cell lines with many of the characteristics of naturally metastatic cells with ampli®ed N-myc genes. Modulation of N-myc and integrin expressions may play a signi®cant role in progression of human neuroblastoma.
Introduction
Human neuroblastoma (NB) includes several related but distinct diseases (Brodeur, 1991) . Survival of patients with late-stage (3 or 4) disease is very low (Bernstein et al., 1992) . Tumor cells from these patients frequently exhibit deletions on the long arm of chromosome 1 (1p36) and ampli®cation of the N-myc oncogene (Brodeur, 1991) . N-myc is a nuclear DNA binding protein of the myc family (Marcu et al., 1992; Ramsay et al., 1986 ) that associates with a protein termed max to modulate DNA binding (Amati et al., 1993; Atchley and Fitch, 1995; Wenzel et al., 1991) . Nmyc binds to the same consensus DNA sequence (CACGTG; Alex et al., 1992; Ma et al., 1993) as cmyc, although the proteins share only a 32% homology . The expression of N-myc is regulated both temporally and spatially during development, and few adult tissues produce the protein (Mugrauer et al., 1988; Zimmerman et al., 1986) . N-myc expression may be under the control of the product of a gene termed heir-1, a candidate NBspeci®c tumor suppressor (Ellmeier et al., 1992) . N-myc and heir-1 exhibit mutually exclusive expression in several NB cell lines and during development in the mouse (Ellmeier et al., 1992) .
Several laboratories have attempted to identify targets for N-myc action. Results have indicated that, in NB cell lines transfected with an N-myc cDNA, expression of (a) components of the major histocompatability complex I (Bernards et al., 1986) , (b) isoforms of protein kinase C (Bernards, 1991; Schmidt et al., 1984) , (c) elements of the NF-kB complex (van't Veer et al., 1993) , and (d) the neural cell adhesion molecule (Akeson and Bernards, 1990 ) are downregulated. In addition, expression of a protein for resistance to several chemotherapy agents (MRP) is upregulated in these cells (Bordow et al., 1994; Norris et al., 1996) . Our laboratory has obtained evidence that integrin extracellular matrix receptor levels are greatly reduced, both in naturally-occurring tumor lines and in N-myc-transfected cell lines, which over-express N-myc (Flickinger et al., 1994; .
Integrins are heterodimeric glycoprotein receptors, composed of one a and one b subunit (Hynes, 1992) . Integrin extracellular domains recognize and attach to components (i.e., ®bronectin, collagen, laminin) of the extracellular matrix; cytoplastic domains serve as a baseplate for assembly of cytoskeletal components and initiate a signal transduction cascade resulting in adhesion-speci®c gene expression (Clark and Brugge, 1995; Schwartz et al., 1995) . Oncogenes that confer adhesion-independent growth upon transformation may short-circuit integrin-dependent signal transduction processes (Schwartz, 1993) .
Our laboratory has investigated neuroblastoma cell adhesion to the extracellular matrix, utilizing a nude mouse model system to analyse relationships between oncogene-dependent eects on adhesion and tumor formation/progression (Flickinger et al., 1994; Kleinman et al., 1994) . NB cell lines which over-express N-myc are more tumorigenic and metastatic when injected into either the subcutaneous space or adrenal glands of nude mice . A relationship was established between enhanced tumor progression and decreased expression of specific integrin subunits. In vitro experiments revealed that transfection and over-expression of N-myc in a NB cell line that does not normally produce the protein resulted in N-myc dose-dependent reduction in the b1 integrin subunit protein , concomitant with an altered cell morphology and loose adhesion to the substratum.
This report presents analyses on the mechanism(s) underlying down-regulation of integrin expression by N-myc. We demonstrate that both a and b1 integrin subunits are greatly decreased by an elevated level of N-myc protein. Interestingly, a subunit expression was reduced more than was b1 expression. N-mycexpressing cell lines were de®cient in cell surface a2b1 and a3b1 complexes. Finally, integrin down-regulation occurs at both transcriptional and post-transcriptional levels.
Results

SKMYC2 cells exhibit high levels of N-myc and low levels of b1 integrin
When N-myc was transfected into and over-expressed in SKNSH cells, which normally express little or no Nmyc, transfected clones exhibited greatly reduced b1 integrin protein levels in an N-myc dose-dependent manner . N-myc-transfected cells could be separated into two distinct subpopulations based upon their relative attachment to plates in culture. Loosely adherent cells contained more N-myc and less b1 protein than did cells that were ®rmly attached to substrata .
Investigations into the inverse relationship between N-myc and b1 integrin levels were pursued using total cell populations from the N-myc-transfected cell line designated SKMYC2. SKMYCAS cells, which were transfected with an N-myc anti-sense construct, were used as a control. Figure 1 shows the results of Western blot analyses on b1 integrin (with an antibody that recognizes both mature and immature forms of b1) and N-myc proteins. b1 protein levels are reduced, while N-myc is produced at relatively high levels in SKMYC2 cells ( Figure 1A and B, lane 2) as compared with SKNSH cells ( Figure 1A and B, lane 1). SKMYCAS cells, which produce little or no N-myc, retain near normal levels of b1 (lane 3). IMR32 cells, which produce very high levels of N-myc, exhibit little or no b1 integrin levels (lane 4). Quantitation of several such Western blots ( Figure 1C) indicates that on average SKMYC2, SKMYCAS or IMR32 cells produce 41%, 100% or 6%, respectively, of the b1 protein level observed in SKNSH cells. SKNSH, SKMYC2 or SKMYCAS cells produce 3%, 35% or 4%, respectively, of the level of N-myc protein as IMR32 cells. Qualitatively similar results were obtained with an independent N-myc-transfected clone designated SKMYC6 data not shown) .
To analyse the stability and maturation state of integrins produced by these cell lines, integrin protein levels were examined by pulse-chase metabolic radiolabeling with [ 35 S]methionine followed by immunoprecipitation (IP). Cells were pulse-labeled for 3 h at 378C, then chased with normal media for 0, 2.5, 5 or 7.5 h. At the indicated chase times, extracts were prepared and IPs were performed using equal amounts of radioactivity from each extract (qualitatively similar results were obtained when the experiment was repeated with equal amounts of protein, data not shown) with an antib1 monoclonal antibody that recognizes both the mature (high molecular weight) and immature (low molecular weight) forms of b1; the results are presented in Figure 2 and Table 1 . It should be noted that the high molecular weight band (H in Figure 2A ) also contains any a3 subunit complexed with b1.
At 0 h, immediately after the 3 h pulse, integrin protein levels in the low molecular weight band ( Figure  2A , L band) were 100%, 48%, 147% or 25% for SKNSH, SKMYC2, SKMYCAS, or IMR32, respectively, relative to that produced by SKNSH (Table 1 , column 2; Figure 2A , lanes 2, 7, 12 and 17). This result is in agreement with that obtained from Western blot analyses (Figure 1 ). During the chase period, it can be seen that precipitated integrins undergo a shift from a low molecular weight to a high molecular weight complex in SKNSH and SKMYCAS cells ( Figure 2A , lanes 2 ± 5 and 12 ± 15); this shift does not occur in SKMYC2 or IMR32 cells (lanes 7 ± 10 and 17 ± 20). It is likely that this molecular weight shift is due to processing and/or maturation of b1 concomitant with its association with a subunits (Bednarczyk et al., 1992; Dalton et al., 1995; Heino et al., 1989) . This shift in maturation form does not occur in cell lines overexpressing N-myc ( Figure 2B ). At 0 h, only a small fraction of integrins are observed to be the high molecular weight form. In SKNSH and SKMYCAS cells, as the chase time is increased, a greater fraction of b1 has matured; after 7.5 h, approximately 50% of the integrin is mature. In SKMYC2 and IMR32 cells, the ratio of high to low molecular weight integrin changes very little, remaining essentially the same after 7.5 h as at 0 h ( Figure 2B) .
Finally, examination of the data in Figure 2A reveals that during the chase the total amount of integrin (high [H] and low [L] forms) remains relatively constant (Table 1 , columns 2 ± 5). For example, for SKNSH cells the amount of integrin (H+L) after 2.5 h of chase was increased, relative to 0 h, but then dropped down to the same level as seen at 0 h by 5 or 7.5 h. In SKMYC2 cells, integrin levels at 2.5 or 5 h appeared to be reduced, relative to 0 h, but was elevated again at 7.5 h. It is unlikely that these dierences are signi®cant.
These results taken together suggest that cell lines which over-express N-myc (a) produce signi®cantly less b1 integrin subunit, and (b) do not mature most of the b1 that is produced. N-myc-overexpressing cells make less b1 integrin and do not mature what is made.
SKMYC2 cells exhibit reduced a/b1 integrin complexes
The results above indicate that SKMYC2 and IMR32 cells do not mature the b1 protein that they do produce. It has previously been suggested that maturation requires association of a and b subunits (Springer et al., 1984) . Therefore, SKMYC2 and IMR32 cells may be de®cient in a integrin subunits as well. To investigate a integrin de®ciency in SKMYC2 cells, IP experiments were performed with antibodies speci®c for b1, a2, or a3 integrins (and antia4 as a negative control) (Flickinger et al., 1994) . Results had demonstrated that a2 and a3 are the predominant partners for b1 in SKNSH cells . Following IP, samples were subjected to Western blot analysis to identify b1 integrin coprecipitated by anti-a integrin antibodies.
IP/Western blot analysis is shown in Figure 3 . b1 integrin was precipitated by antibodies to b1, a2 and a3 integrin in SKNSH cells ( Figure 3 , lanes 2 ± 4). Similar results were obtained with SKMYCAS cells (lanes 9 ± 11). However, little or no b1 was precipitated in SKMYC2 (lanes 6 ± 8) or IMR32 (lanes 12 ± 14) cells, either by the b1 antibody (monoclonal antibody At the indicated chase times after the pulse, extracts were prepared and IPs were performed using 3610 6 c.p.m. of labeled extract per IP in the absence (lanes 1, 6, 11 and 16) or presence (lanes 2 ± 5, 7 ± 10, 12 ± 15 and 17 ± 20) of anti-b1 monoclonal antibody DF5. IPs were subject to reducing SDS ± PAGE on 6% (w/v) polyacrylamide; gels were then processed for¯uorography and dried. The ®gure is a nine day exposure of a¯uorogram. A molecular mass marker and the migration positions of the high (H±) and low (L±) molecular weight integrin isoforms are indicated on the left. (B) Thē uorogram in part (A) was subjected to scanning densitometry, and the relative amounts of integrin in the high or low molecular weight isoforms were quantitated. The ®gure shows a bar graph of the ratio of H± to L±b1 at various times of chase (open bars, 0 h; horizontally striped bars, 2.5 h; black bars, 5 h; vertically striped bars, 7.5 h) in the indicated cell lines P4C10, which only recognizes the mature form of b1) or by antibodies to a2 or a3 integrin. In addition, none of the cell lines produce a/b1 complexes utilizing a4 or a5 integrins (data not shown). It can be concluded that the small amount of b1 that does mature in SKMYC2 cells is not associated with a2 or a3 subunits.
To analyse directly for production of a integrin subunits, cytoplasmic/membrane extracts were detergent-solubilized from SKNSH, SKMYC2, SKMYCAS or IMR32 cells and were then reacted with sulfo-NHSbiotin, which reacts with primary amine-containing amino acid residues. Following biotinylation, IPs were performed, samples were separated by SDS ± PAGE, gels were blotted to nitrocellulose, and biotinylated/ immunoprecipitated integrins were detected with streptavidin-horse radish peroxidase and¯uorography ( Figure 4 ). Biotinylated integrins were immunoprecipitated from SKNSH cells by antibodies against b1, a2 or a3 subunits as expected (lanes 2 ± 4); the same was true for SKMYCAS cells (lanes 9 ± 11). b1 was detected in SKMYC2 cells by this method (by an antibody that recognizes mature and immature forms of b1), but only about 40% of that seen in SKNSH cells (lane 6).
IMR32 cells contained even less b1 (lane 12, 24% of SKNSH). In addition, very small amounts of integrins were detected by IP with antibodies to a2 or a3 integrin in SKMYC2 or IMR32 cells.
The combined results from the experiments in Figures 3 and 4 indicate that SKMYC2 and IMR32 cell lines not only produce decreased amounts of b1 subunit (in relation to the amounts of N-myc they produce), but that they are even more de®cient in a2 and a3 subunits.
Integrin cell surface expression is greatly reduced in SKMYC2 cells
It was next important to examine the cell surface expression of integrins. Initial experiments utilized biotinylation of non-permeabilized cells, followed by IP and Western blot analysis ( Figure 5 ). IPs were performed with antibodies against b1 (mature form only), a2, or a3 (anti-a4 was used as a negative control) integrin subunits. SKNSH cells have relatively large amounts of b1, a2 and a3 on the cell surface (lanes 2 ± 4), as do SKMYCAS cells (lanes 9 ± 11). Surprisingly, SKMYC2 and IMR32 cells exhibit some cell surface b1 (lanes 6 and 12, respectively; 10% and 4% of that detected on SKNSH cells). However, neither of these cell lines appear to have any a2 or a3 integrin on the cell surface (lanes 7 ± 8 and 13 ± 14). This result suggests the intriguing possibility that the cell lines which overexpress N-myc (SKMYC2 and IMR32) produce small amounts of an a integrin subunit that has not yet been identi®ed but which associates with b1, allowing small amounts of the complex to get to the cell surface.
In order to con®rm the results obtained with cell surface biotinylation, FACS analyses were performed for cell surface b1 subunit levels (Table 2) . Some b1 does appear on the surfaces of SKMYC2 and IMR32 cells (18% and 14% of that detected on SKNSH cells). It will be of interest to identify the a subunit expressed in these cells that associates with b1 integrin on the cell surface, since these cells do not produce most of the common collagen/®bronectin-binding integrins (Flickinger et al., 1994; . 1 2 3 4 5 6 7 8 9 10 11 12 13 14 199 -120 -
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Figure 3 Co-IP of b1 integrin by anti-a integrins. Fifty mg of cytoplasmic extracts from the indicated cell lines were incubated with no antibody, or with P4C10 (b1), P1H6 (a2), P1B5 (a3) or P4G9 (a4) monoclonal antibodies. Immune complexes were precipitated with anti-mouse IgG-agarose, washed, and processed for SDS ± PAGE on 7.5% (w/v) polyacrylamide gels. After electrophoresis, gels were blotted to nitrocellulose; membranes were probed with anti-b1 integrin AB1938P. The migration position of b1 integrin or molecular mass standards are indicated on the right or left, respectively. The ®gure is a¯uorogram 1 2 3 4 5 6 7 8 9 10 11 12 13 14 199 -120 -
Figure 4 IP of extract-biotinylated integrins. Detergent-solubilized extracts were biotinylated and 50 mg of extract protein from the indicated cell lines were treated with anti-integrin antibodies as described in the legend to Figure 3 , except that b1 IPs were performed with the monoclonal antibody DF5. Immune complexes were precipitated, processed for SDS ± PAGE, and separated on 6% (w/v) polyacrylamide gels, which were blotted to nitrocellulose. Membranes were probed with streptavidin-horse radish peroxidase conjugate. The migration position of b1 integrin or molecular mass standards are indicated on the right or left, respectively. The ®gure, which is a¯uorogram, depicts a ®lm which was overexposed in order to demonstrate integrins precipitated by P1B5 from SKMYC2 cells (lane 8)
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Figure 5 IP of cell surface-biotinylated integrins. The indicated cells were detached from plates and biotinylated in suspension as non-permeabilized populations. Biotinylated cells were used for extract preparation and 50 mg of extract from the indicated cell lines were precipitated with monoclonal antibodies as described in the legend to Figure 3 . IP, SDS ± PAGE and detection were as described in the legend to Figure 4 . The migration position of b1 integrin or molecular mass standards are indicated to the right or left, respectively. The ®gure, which is a¯uorogram, depicts a ®lm which was overexposed in order to demonstrate integrins precipitated by P1B5 from SKMYC2 cells (lane 8)
Integrin expression is dierentially reduced at the mRNA level in SKMYC2 and IMR32 cells
As a preliminary analysis of the mechanism(s) underlying reduced integrin protein levels in N-myc overexpressing cells, Northern blots were performed (with a probe recognizing the entire b1 mRNA) on total cellular RNA from SKNSH, SKMYC2, SKMYCAS or IMR32 cells ( Figure 6 ). In this particular result, b1 integrin mRNA was reduced 53% in SKMYC2 (lane 2) and 83% in IMR32 cells (lane 4) as compared with SKNSH cells (lane 1), relative to b-actin. b1 integrin mRNA levels were not aected in SKMYCAS cells (lane 3). In addition, a single band of identical size was detected in all four cell lines, indicating that the reductions seen in b1 mRNA and total cell protein are not due to production of alternatively spliced mRNAs. Ribonuclease Protection Assay (RPA) analysis was performed to quantify the reduction of b1 mRNA and to conveniently probe for the expression of several genes (Table 3, Figure 7 ). As loading controls, RPAs were performed with probes detecting b-actin mRNA and 18s rRNA ( Figure 7C and D) . The level of 18s rRNA did not¯uctuate signi®cantly relative to the level of actin; therefore, the actin probe was utilized as a loading control in the remainder of the assays. RPAs were performed on actin versus b1, a2 and a3 integrin mRNAs ( Figure 7A and C) and on actin versus N-myc and max mRNAs ( Figure 7B and D) . Max is a mycassociated protein required to mediate DNA binding of myc proteins (Amati et al., 1993) . All three integrin mRNA levels were reduced in SKMYC2 and IMR32 cells as compared with SKNSH cells (Figure 7A and C). b1, a2 and a3 mRNAs were reduced 52%, 80% and 94%, respectively, in SKMYC2 cells as compared with SKNSH cells. Integrin mRNA levels were similarly reduced in IMR32 cells. In SKMYCAS cells, b1 levels were similar to those seen in SKNSH cells; a2 and a3 mRNA levels were nearly doubled. Nmyc mRNA was nearly undetectable in SKNSH and SKMYCAS cells (Figure 7B and D) and very high in IMR32 cells. SKMYC2 cells produced 12% of the level of N-myc mRNA expressed by IMR32 cells. Max mRNA levels¯uctuated somewhat, but the results indicate that max levels are not decreased (as are integrin mRNA levels) in the N-myc-expressing cell lines. Similar results were obtained with SKMYC6 cells; integrin (b1, a2 and a3) mRNA levels were greatly reduced, while max mRNA levels were not in this independent clone (data not shown). These data indicate a much greater down-regulation of a than b1 subunit mRNAs.
Discussion
A characteristic feature of late-stage metastatic NB is ampli®cation and over-expression of N-myc. N-myc is a nuclear DNA-binding protein (Marcu et al., 1992; Ramsay et al., 1986 ) ± i.e. a transcription factor. Unfortunately, little direct evidence has been presented regarding genes under transcriptional control Figure 6 Northern blot analysis of b1 integrin mRNA levels. Total cellular RNA was prepared from the indicated cell lines, and 20 mg was processed for denaturing agarose gel electrophoresis. Separated RNAs were blotted to nylon membranes and were probed for b1 integrin (a) or b-actin (b). The migration position of b1 integrin mRNA, b-actin mRNA, or ribosomal RNAs are indicated on the right or left, respectively. The ®gure is an autoradiogram (Bernards, 1991; Schmidt et al., 1984) , resulting in the downregulation of expression of the major histocompatibility complex I (Bernards et al., 1986) . N-myc may also up-regulate expression of the multi-drug resistance protein MRP (Bordow et al., 1994; Norris et al., 1996) . Our previous results established correlative inverse relationships between the levels of N-myc and b1 integrin subunit, as well as between integrin expression and progression of NB in a nude mouse model system (Flickinger et al., 1994; . Transfection and over-expression of N-myc was demonstrated to reduce b1 protein levels in an Nmyc-dose dependent manner in human SKNSH cells which express little or no N-myc but which do express high levels of b1, a2 and a3 integrin subunits . The data presented here extend these relationships and provide results regarding the mechanisms underlying reduced integrin levels ( Figure  8 ). Both the naturally-occurring IMR32 and N-myctransfected SKMYC cell lines exhibit reduced levels of b1 and two dierent a integrin subunits. Reduced totalcell levels of these integrin subunits are re¯ected in greatly reduced cell surface integrin levels as determined by cell surface biotinylation and by FACS analysis. While virtually no a2 or a3 were detected at the cell surface, some mature b1 was detected, presumably in association with an unidenti®ed a subunit. Our results suggest that overall reductions in integrin protein levels are the result of reductions in integrin mRNA levels, with a integrin mRNA levels being more reduced than the b1 mRNA levels.
That N-myc over-expression down-regulates the level of integrin mRNAs suggests that N-myc may be exerting a negative regulatory eect on transcription from some integrin gene promoters, especially since Nmyc is a DNA-binding protein. An N-myc consensus DNA binding site (E-box, CACGTG) is present in the b1 integrin promoter (nucleotides 816 to 821 from the 5' end (Cervella et al., 1993) ). A second nonconcensus site (that binds N-myc (CATGCG; ) is present from nucleotides 475 to 480. These two sites are located approximately 550 and 900 base pairs, respectively, upstream from the principle b1 transcription initiation sites (Judware and Culp, personal observations) . No consensus sites are present in the promoter for a2 integrin (Zutter et al., 1994) ; however, there are two nonconsensus sites , one at 7156 to 7151 (CGCGTG) and one at 7360 to 7355 (CACGTT), relative to the site of a2 transcription initiation (Judware and Culp, personal observations). The promoter for a3 integrin has not yet been characterized.
Our results indicate that b1 mRNA levels were reduced twofold, while a2 and a3 levels were decreased ®vefold and 16-fold, respectively, in SKMYC2 or IMR32 cells (Figure 8 ). If these levels actually re¯ect eects on the respective integrin gene promoters by an N-myc-containing complex, then our data imply that the a integrin promoters are more sensitive to N-myc (with the a3 promoter being the most sensitive) than is the b1 promoter. However, more direct transcriptional analyses will be required to test these hypotheses.
That N-myc itself is a regulatory element is supported by the observation that max is produced at constitutive levels in all cell lines examined in this study. Max is one of a family of myc-associated cofactors (Amati et al., 1993; Atchley and Fitch, 1995; Ayer et al., 1993; Zervos et al., 1993) which modulate DNA binding by myc proteins. It is thought that the relative levels of myc, max, mad and mxi control the DNA binding ability and anity of myc proteins (Bernards, 1995; Chin et al., 1995; Kretzner et al., 1992) for E-box motifs. In addition to eects on integrin mRNA levels, Nmyc over-expressing cell lines (i.e., SKMYC2 and IMR32) also utilize post-transcriptional mechanisms to modulate integrin cell surface expression (Figure 8) . Little or no a2 or a3 protein is produced from the small amounts of mRNA that are present, suggesting a further post-transcriptional block in expression of these subunits. b1 integrin protein is produced at a level commensurate with the level of its mRNA. However, in the absence of signi®cant amounts of a2 or a3 protein, the b1 protein does not mature eectively and only small amounts get to the cell surface complexed with an unknown a subunit. Either the absence of a2 or a3 subunits stalls the maturation of b1 protein, or the high levels of N-myc protein produce a second unde®ned mechanism which halts b1 maturation. Additional experiments will be required to identify the exact regulatory mechanisms.
The data presented herein suggest that N-myc overexpression greatly reduces the levels of a2b1 and a3b1 integrins in highly-progressing NB cells, both naturallyoccurring and arti®cially-induced. Interestingly, N-myctransfected cell lines phenotypically resemble natural N-myc over-expressing cell lines, such as IMR32, in many respects. Eorts can now be focused upon the precise molecular mechanisms operating at both the transcriptional and post-transcriptional levels that govern regulation of integrin expression by N-myc.
These results support a model for the progression of human NB. Most NB cell lines and tumors contain chromosome 1p36 deletions (Brodeur, 1991) , possibly resulting in loss of a NB-speci®c tumor suppressor gene. One candidate for this tumor suppressor has been identi®ed as heir-1 (Ellmeier et al., 1992; Ellmeier et al., 1996) . Heir-1 and N-myc exhibit mutually exclusive expression in several NB cell lines and during development in the mouse (Ellmeier et al., 1992) . Nmyc and several integrin subunits also exhibit mutually exclusive expression (Flickinger et al., 1994; this work) . Deletion of heir-1 (or a similar gene) may lead to overexpression (and ampli®cation?) of the N-myc oncogene (Cheng et al., 1995) . Consequently, over-expressed Nmyc down-regulates integrin expression. 1p36 deletions are found in both early-stage (non-metastatic) and aggressive late-stage (metastatic) NBs; N-myc amplification and over-expression is more commonly associated with metastatic NB.
It is easy to conceptualize how altered integrin expression may contribute to tumor progression. Some tumor cell types down-regulate (as shown herein) while other tumor cell types up-regulate the expression of integrins, as compared with untransformed parental cells (Albelda, 1993; Ruoslahti and Giancotti, 1989) . Loss of integrins would promote detachment of tumor cells from the primary parent tumor. Expression of new integrins would promote adhesion to, and colonization of, new tissues. This may be an oversimpli®caton of the metastatic process, as it does not consider the myriad of other factors (i.e., activating oncogene, growth factor/receptor expression patterns of tumors and tissues, angiogenic capacity, etc) that must all come together correctly for successful metastasis. Nevertheless, our observations of N-myc over-expression and integrin down-regulation facilitate the understanding of the role of this particular oncogene in human neuroblastoma. (Indianapolis, IN) ; pre-stained molecular mass standard proteins, and anti-mouse IgG-, anti-rabbit IgG-and streptavidin-horse radish peroxidase conjugates from BioRad (Hercules, CA). All other reagents and supplies were from Sigma (St. Louis, MO) unless otherwise noted.
Materials and methods
Materials
Cell culture and extract preparation
All cell lines were maintained in DMEM supplemented with antibiotics and 10% newborn calf serum (normal media) at 378C under 10% CO 2 . Cultures of SKMYC2, SKMYC6, or SKMYCAS cells were supplemented with 800 or 200 mg/ml hygromycin B as described . For experiments, all cell lines were passaged just prior to reaching con¯uence and inoculated into 100 mm plates. For extract preparation, cells were detached from plates by incubating for 5 min in Figure 8 Model for regulation of integrin expression by N-myc in NB. The ®gure outlines features of integrin expression in Nmyc over-expressing NB cell lines (i.e., SKMYC2 or IMR32). Transcription from the integrin genes produces mRNA which is translated into immature integrin proteins; immature a's and b1 associate, mature, and translocate to the cell surface. The relative eects of N-myc expression on integrin mRNA levels, total protein levels, and cell surface protein levels are shown. b1 mRNA levels are reduced approximately twofold, a2 ®vefold and a3 16-fold. b1 total protein levels were reduced 60%, while no a integrin proteins were detected (ND). Maturation of the b1 subunit was prevented by the absence of a subunits, resulting in ®ve-to 10-fold reductions in cell surface b1; no a2 or a3 protein was detected on the cell surface phosphate-buered-saline (PBS) containing 1 mM EDTA. Cell suspensions were enumerated on a hemocytometer and cells were collected by centrifugation at 500 g. Extracts for all experiments were prepared at 10 6 cells per 50 ml as described ; protein concentrations in extracts were determined by the BCA Protein Assay (Pierce, Rockford, IL). RNA samples for Northern blot or RPA analyses were prepared using RNAzol B (BIOTECX Laboratories, Inc., Houston, TX) as recommended; RNA concentrations were determined by absorbance at 260 nm.
Pulse-chase radiolabeling and biotinylation
For pulse-chase metabolic radiolabeling experiments, cultures in 100 mm plates (90% con¯uent) were incubated for 3 h at 378C in 5 ml DMEM without methionine or cysteine (ICN, Costa Mesa, CA) Cell surface biotinylation (to evaluate cell surface integrin levels) was performed by detaching cells from culture plates (as above) and washing cell suspensions with and resuspending in ice-cold PBS containing 1 mM MgCl 2 /1 mM CaCl 2 at 10 7 cells/ml. Sulpho-NHS-Biotin (Pierce, Rockford, IL) was added to a ®nal concentration of 3.5 mM, and then suspensions were incubated for 1 h at 48C with gentle rotation. Biotinylation was stopped by the addition of NH 4 Cl (1 M, in water) to 30 mM; then cells were washed three times with ice-cold PBS and used for preparation of extracts and protein determination.
To evaluate whole-cell integrin levels, cytoplasmic/ membrane extracts were biotinylated in a reaction mixture containing 50 mM HEPES (pH 8.5), 1 mg/ml extract protein, 1 mM phenylmethylsulfonyl¯uoride, 1.8 ng/ml aprotinin, 0.5 ng/ml leupeptin and 30 mM sulfo-NHS-biotin. Reactions were incubated 1 h at 48C with gentle rotation; biotinylation was stopped by the addition of lysine (1 M, in water, pH 9.0) to 2 mM.
Immunoprecipitation and Western blot analyses
IPs were performed with 50 mg of protein from unlabeled, whole-cell-biotinylated or cell surface-biotinylated, or with 3610 6 c.p.m. of radiolabeled extracts. Antibodies used include anti-b1 integrin monoclonal antibody DF5 (1 mg per IP; ICN) or P4C10 (anti-b1); P1H6 (anti-a2); P1B5 (anti-a3); or P4G9 (anti-a4) cell culture supernatants (20 ml per IP). Extracts and antibody preparations were incubated for 2 h at 48C with gentle rotation, and then 15 ml of antimouse IgG-agarose beads (for unlabeled extracts) or 10 ml of protein A-Sepharose beads (pre-bound with 200 mg of rabbit anti-mouse IgG [ICN] for biotinylated or radiolabeled extracts) were added to each reaction and incubation was continued for 1 h. Complexes precipitated with rabbit anti-mouse IgG-agarose were washed six times with 50 mM tris (pH 8.0)/150 mM NaCl/0.5% (v/v) NP-40/0.1% (w/v) SDS/0.5% (w/v) deoxycholate, once with PBS and once with water. IPs with protein A-Sepharose were washed twice each with tris-buered-saline (TBS: 10 mM tris [pH 7.5]/150 mM NaCl); also TBS/0.5% (v/v) triton X-100, TBS/0.25% (w/v) SDS, TBS/1% (v/v) triton X-100/0.5% (w/v) SDS/1% (w/v) deoxycholate, 0.5 M LiCl and once with water.
Precipitated integrin complexes were solubilized from beads and processed for SDS ± PAGE by the addition of SDS-sample buer (Laemmli, 1970) and boiling. Unlabeled extracts for Western blot analysis were processed in a similar manner. Electrophoresis was performed on the indicated acrylamide gels. Where indicated, protein pro®les were transferred to nitrocellulose. Membranes were blocked for 30 min in PBST (PBS/0.05% (v/v) Tween-20) containing 3% (w/v) non-fat dry milk. Membranes from gels containing crude extracts or from gels containing IPs from unlabeled extracts were incubated with the indicated antibody: AB1938P (anti-b1, Chemicon, Temecula, CA), DF5 (antib1), or NCMII100 (anti-N-myc; Oncogene Science, Inc., Uniondale, NY) at a concentration of 0.15 mg/ml in blocking solution for overnight at 48C as indicated. Membranes were washed three times with PBST and were then incubated with 1:2000 dilute (in blocking solution) anti-rabbit IgG-(for AB1938P) or anti-mouse IgG-(for DF5 or NCMII100) horse radish peroxidase conjugate for 1 h. Membranes from IPs of biotinylated extracts were blocked and then incubated for 45 min in streptavidin-horse radish peroxidase conjugate diluted 1:10 000 in PBST. All membranes were then washed three times with PBST, exposed to Lumiglo (Kirkegaard and Perry Labs, Gaithersburg, MD) chemiluminescent substrate for 1 min, and then exposed to X-ray ®lms. Fluorography varied from a few seconds to a few minutes; band intensity was linear with respect to exposure time. Followinḡ uorography, membranes were stained with Ponceau S to con®rm equal protein loading. Scanning densitometry of uorograms was performed on a SciScan 5000 scanning densitometer (United States Biochemical, Cleveland, OH).
After SDS ± PAGE on 6% (w/v) polyacrylamide, gels from [ 35 S]-radiolabeled IPs were ®xed for 1 h in 10% (v/v) acetic acid, were then incubated for 30 min in Amplify (Amersham), dried and exposed to X-ray ®lms (which were quantitated by scanning densitometry) for 10 days.
Fluorescence-activated cell sorting
For FACS analysis, cells were detached from¯asks by incubation in PBS containing 2 mM EDTA for 20 min at 378C. Detached cells were enumerated on a hemocytometer, collected by centrifugation for 5 min at 500 g, washed once with PBS, and were then washed three times with ice-cold FM (PBS/1 mM CaCl 2 /1 mM MgSO 4 /0.5% (w/v) bovine serum albumin/0.01% (w/v) NaN 3 ). Cells were resuspended at 2610 6 cells/ml in FM; then 2610 5 cells were diluted to 180 ml with FM and incubated for 1 h on ice with 20 ml of PBS (negative control), P4G9 (anti-a4 integrin) or P4C10 (anti-b1 integrin antibody). After incubation, cells were washed twice with ice-cold FM and were then resuspended with 160 ml FM. Fluorescein isothiocyanate-anti-mouse-IgG (40 ml, diluted 1:40 in FM) was added, and cells were incubated for 40 min on ice. Cells were then washed four times with FM and used for analysis on a FACScan¯ow cytometer (Becton-Dickinson). For each sample, 2000 cells were analysed; the mean uorescent intensity (MFI) for the entire population of cells is reported.
Northern blot analysis
Neuroblastoma RNA (20 mg per lane) was denatured and separated by electrophoresis on agarose-formaldehyde gels as described (Sambrook et al., 1989) . Gels were blotted to nylon membranes which were sequentially probed for b1 integrin or b-actin mRNA. The b1 probe encompasses the entire b1 integrin cDNA from pECEb1 (provided by Dr E Ruoslahti, La Jolla Cancer Research Foundation, La Jolla, CA) (Argraves et al., 1987) . The actin probe contains exon 3 (bp 521 ± 819) from the human b-actin cDNA (provided by Dr F Rottman, Case Western Reserve University). Gel puri®ed-probe DNAs were labeled using the Random Primed DNA Labeling Kit in the presence of 50 mCi [a-
32 P]ATP (3000 Ci/mmol); probe speci®c activity was typically 10 9 c.p.m./mg. Probe DNA was hybridized overnight with RNA on the membranes; then membranes were washed with 0.26SSC (16=15 mM sodium citrate [pH 7.5]/150 mM NaCl) containing 0.2% SDS at sequentially higher temperatures until background radioactivity on the membranes was less then 400 c.p.m. Membranes were then exposed to X-ray ®lms for 12 ± 48 h. Autoradiograms were used for quantitation by scanning densitometry.
Preparation of plasmid constructs, transcription reactions and RPA All RPA vectors (except pRPAMax) were constructed using pBluescript as the base plasmid; vectors include pRPAActin, pRPAb1, pRPAa2, pRPAa3, pRPANmyc and pRPAMax (Table 3 ). All restriction enzymes selected to linearize these constructs leave 5' protruding ends on the respective vectors. pRPAActin contains the 5' 150 basepairs (bp) of the human b-actin cDNA (from pBR-Actin); linearization with AccI followed by transcription with T3 polymerase yields the 85 nucleotide probe indicated in Table 1 . pRPAb1 includes nucleotides 604 ± 1622 from the human b1 integrin cDNA; the construct was linearized with StuI and transcribed with T7 polymerase. pRPAa2 was prepared with the 5' 1790 bp of the human a2 integrin cDNA (from phia2, American Type Culture Collection, clone 2.72F (Takada and Hemler, 1989) ); the plasmid was linearized with BstEII and transcribed with the T3 polymerase. pRPAa3 contains 328 bp (2919 ± 3247) of the human a3 integrin cDNA (provided by Dr M Hemler, Dana Farber Cancer Institute, Boston, MA (Takada et al., 1991) ), was linearized with NaeI and transcribed with the T7 polymerase. pRPANmyc encompasses the NB-1 region of the human N-myc cDNA (provided by J M Bishop, University of California at San Francisco, San Francisco, CA), was linearized with NarI and was transcribed with the T7 polymerase. pRPAMax was generated by removing the 3' 360 bp ApaI fragment from pVZ1 (provided by Dr R Eisenman, Fred Hutchinson Cancer Research Center, Seattle, WA (Blackwood and Eisenman, 1991) ); linearization was with EcoRI and transcription was with the T7 polymerase. Table 3 lists each vector with the region of the mRNA, the sizes of the transcript and the RNA fragment protected.
Transcription reactions were performed essentially as described (Promega Protocols and Applications Guide, 1991) in the presence of 50 mCi [a-32 P]UTP (800 Ci/mmol). Transcripts were puri®ed by electrophoresis on 8 M urea/5% (w/v) polyacrylamide gels as described (Ambion, RPA Kit Instruction Manual). RPAs were performed with the RPA I Kit (Ambion, Austin, TX) as per the manufacturer's instructions. Reactions contained 5 mg of neuroblastoma RNA, 10 5 c.p.m. of actin probe and 5610 4 c.p.m. of probe for the indicated mRNAs. These amounts of probe were empirically determined to provide at least a 10-fold molar excess of probe over target RNA. After overnight hybridization of RNA and probe, reactions were digested with a combination of RNases A and T1, phenol-extracted, ethanolprecipitated and electrophoresed on 8 M urea/5% (w/v) polyacrylamide gels. After electrophoresis, gels were ®xed, dried and exposed to X-ray ®lms for 12 ± 48 h. Autoradiograms were quantitated by scanning densitometry.
Abbreviations FACS,¯uroescence-activated cell sorting; IP, immunoprecipitation; NB, neuroblastoma; RPA, ribonuclease protection assay
